サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563124

止血剤および組織シーリング剤の世界市場：製品・材料・用途・エンドユーザー・地域別の予測 (～2032年)

Global Hemostasis and Tissue Sealing Agents Market Research Report Information by Product, By Material, By Application, By End-User, and Region Forecast till 2032

出版日
ページ情報
英文 132 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
止血剤および組織シーリング剤の世界市場：製品・材料・用途・エンドユーザー・地域別の予測 (～2032年)
出版日: 2024年08月10日
発行: Market Research Future
ページ情報: 英文 132 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血剤および組織シーリング剤の市場規模は、2023年の83億9,000万米ドル、2024年の90億2,000万米ドルから、予測期間中は8.04%のCAGRで推移し、2032年には181億9,000万米ドルの規模に成長すると予測されています。交通事故や慢性血液疾患の発生率の上昇、低侵襲手術に対する世界の需要、高齢化などの要因が市場拡大の原動力となっています。

慢性血液疾患の有病率の増加は市場成長を促進する要因です。血友病やvon Willebrand病のような特定の血液疾患患者は、凝固因子が低下しているため出血しやすいです。血液凝固を促進し、出血を抑制する止血剤は、これらの疾患を持つ人々に対する外科的処置や薬による介入に必要となる場合があります。International Society on Thrombosis and Hemostasisの2022年最新版では、静脈血栓塞栓症は世界で毎年約1,000万件発生していると推計されています。また、同組織によると、欧州では毎年54万4,000人が深部静脈血栓症 (DVT) で死亡しています。

地域別インサイト

北米剤市場は2023年に最大の市場シェアを占めました。高齢化、慢性疾患の増加、医療技術の進歩が進んでいるためです。患者の転帰の改善と術後合併症の低減に焦点を当てた同市場は、R&Dの拠点へと発展し、優れた有効性を持つ新規治療が導入されるようになっています。

欧州市場は、良好な医療政策とカウンセリングを含む併用療法により、第2位の市場シェアを占めると推定されています。

アジア太平洋市場は2024年から2032年にかけてもっとも速い速度で発展すると推定されています。これは、急速な経済の拡大、中間層の増加、都市化の進展によるものです。同地域の人口増加は、医療、技術、消費者製品への需要を促進しています。インフラ、教育、技術への旺盛な投資が産業の発展と技術革新を促進しています。

当レポートでは、世界の止血剤および組織シーリング剤の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 交通事故と慢性血液疾患の発生率の増加
    • 低侵襲手術が好まれる傾向
  • 抑制要因
    • 高いコストと厳しい規制要件
  • 機会
    • 交通事故の増加と高齢者人口の増加

第5章 市場要因分析

  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響
  • 軍事目的の止血剤および組織シーリング剤

第6章 世界の止血剤および組織シーリング剤市場：製品別

  • 概要
  • 局所止血剤
    • アクティブ
    • メカニカル
    • 流動性
  • 接着剤および組織シーラント
    • 合成組織シーラント
    • 天然組織シーラント
    • 癒着防止剤

第7章 世界の止血剤および組織シーリング剤市場：材料別

  • 概要
  • キトサンベース製品
  • ミネラルベース製品

第8章 世界の止血剤および組織シーリング剤市場：用途別

  • 概要
  • 外傷
    • 火傷
    • 事故
    • その他
  • 一般外科
  • 低侵襲手術
  • 婦人科
  • その他

第9章 世界の止血剤および組織シーリング剤市場：エンドユーザー別

  • 概要
  • 病院
    • 公共
    • 民間
    • 軍
  • 外来手術センター
    • 独立外来手術センター
    • 軍の外来手術センター
  • 研究機関

第10章 世界の止血剤および組織シーリング剤市場：地域別

  • 世界
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合情勢

  • 市場シェア分析
  • 競合ダッシュボード
  • 公開企業の株式概要
  • 主要企業の財務動向
  • 主な展開と成長戦略

第12章 企業プロファイル

  • JOHNSON & JOHNSON SERVICES, INC
  • B. BRAUN SE
  • MIL LABORATORIES PVT. LTD
  • BECTON, DICKINSON, AND COMPANY
  • PFIZER INC.
  • TELEFLEX INCORPORATED
  • MEDTRONIC
  • BAXTER
  • MEDTRADE PRODUCTS LIMITED
  • AXIO BIOSOLUTIONS PVT LTD

第13章 データ引用

図表

LIST OF TABLES

  • TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACTIVE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MECHANICAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR FLOWABLE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR SYNTHETIC TISSUE SEALANT, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR NATURAL TISSUE SEALANT, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESION BARRIER PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR CHITOSAN-BASED PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MINERAL BASED PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR BURNS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 22 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MAJOR ACCIDENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MINOR ACCIDENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 25 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR GENERAL SURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 26 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MINIMALLY INVASIVE SURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 27 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR GYNAECOLOGY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 28 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 29 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 30 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 31 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 32 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR PUBLIC, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 33 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR PRIVATE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 34 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MILITARY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 35 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 36 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 37 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR INDEPENDENT AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 38 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MILITARY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 39 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 40 GLOBAL: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 41 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 42 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 43 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 44 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 45 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 46 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 47 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 48 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 49 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 50 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 51 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 52 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 53 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 54 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 55 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 56 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 57 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 58 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 59 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 60 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 61 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 62 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 63 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 64 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 65 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 66 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 67 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 68 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 69 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 70 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 71 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 72 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 73 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 74 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 75 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 76 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 77 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 78 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 79 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 80 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 81 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 82 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 83 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 84 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 85 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 86 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 87 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 88 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 89 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 90 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 91 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 92 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 93 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 94 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 95 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 96 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 97 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 98 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 99 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 100 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 101 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 102 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 103 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 104 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 105 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 106 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 107 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 108 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 109 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 110 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 111 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 112 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 113 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 114 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 115 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 116 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 117 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 118 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 119 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 120 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 121 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 122 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 123 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 124 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 125 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 126 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 127 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 128 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 129 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 130 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 131 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 132 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 133 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 134 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 135 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 136 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 137 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 138 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 139 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 140 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 141 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 142 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019-2032 (USD MILLION)
  • TABLE 143 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 144 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 145 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 146 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 147 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 148 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 149 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 150 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 151 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 152 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 153 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 154 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 155 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 156 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 157 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 158 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 159 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 160 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 161 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 162 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 163 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 164 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 165 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 166 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 167 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 168 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 169 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 170 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 171 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 172 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 173 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 174 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 175 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 176 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 177 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 178 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 179 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 180 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 181 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 182 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 183 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 184 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 185 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 186 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 187 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 188 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 189 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 190 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 191 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 192 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 193 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 194 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 195 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 196 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 197 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 198 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 199 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 200 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 201 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 202 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 203 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 204 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 205 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 206 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 207 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 208 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 209 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 210 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 211 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 212 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 213 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 214 REST OT THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 215 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 216 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 217 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 218 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 219 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 220 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 221 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 222 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 223 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 224 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 226 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 228 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 229 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 235 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
  • TABLE 236 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 237 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 238 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019-2032 (USD MILLION)
  • TABLE 239 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
  • TABLE 240 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 241 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 242 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 243 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 244 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 245 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 246 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 247 PRODUCT LAUNCH/ PRODUCT APPROVAL
  • TABLE 248 ACQUISITION
  • TABLE 249 JOHNSON & JOHNSON SERVICES, INC: PRODUCT OFFERED
  • TABLE 250 JOHNSON & JOHNSON SERVICES, INC: KEY DEVELOPMENTS
  • TABLE 251 B. BRAUN SE: PRODUCT OFFERED
  • TABLE 252 MIL LABORATORIES PVT. LTD: PRODUCT OFFERED
  • TABLE 253 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 254 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS
  • TABLE 255 PFIZER INC.: PRODCUTS OFFERED
  • TABLE 256 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 257 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 258 BAXTER: PRODUCTS OFFERED
  • TABLE 259 MEDTRADE PRODUCTS LIMITED: PRODCUTS OFFERED
  • TABLE 260 MEDTRADE PRODUCTS LIMITED: KEY DEVELOPMENTS
  • TABLE 261 AXIO BIOSOLUTIONS PVT LTD: PRODCUTS OFFERED
  • TABLE 262 AXIO BIOSOLUTIONS PVT LTD: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
  • FIGURE 5 VALUE CHAIN: GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET
  • FIGURE 7 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY PRODUCT,
  • FIGURE 9 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2022 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY MATERIAL,
  • FIGURE 11 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)
  • FIGURE 12 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY APPLICATION,
  • FIGURE 13 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2022 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY END USER,
  • FIGURE 15 GLOBAL: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2022 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY REGION,
  • FIGURE 17 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 18 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 19 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 20 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 21 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 22 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 23 REST OT THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2022 & 2030 (USD MILLION)
  • FIGURE 24 REST OT THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY REGION,
  • FIGURE 25 HEMOSTASIS AND TISSUE SEALING AGENTS MARKET PLAYERS: COMPETITIVE ANALSIS,
  • FIGURE 26 COMPETITOR DASHBOARD: GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET
  • FIGURE 27 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 JOHNSON & JOHNSON SERVICES, INC: SWOT ANALYSIS
  • FIGURE 29 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW
  • FIGURE 31 PFIZER INC.: FINANCIAL OVERVIEW
  • FIGURE 32 PFIZER INC.: SWOT ANALYSIS
  • FIGURE 33 TELEFLEX INCORPORATED: FINANCIAL OVERVIEW
  • FIGURE 34 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 35 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 36 BAXTER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 BAXTER: SWOT ANALYSIS
  • FIGURE 38 MEDTRADE PRODUCTS LIMITED: SWOT ANALYSIS
目次
Product Code: MRFR/HC/6090-CR

Global Hemostasis and Tissue Sealing Agents Market Research Report Information by Product (Topical Hemostat, Adhesive & Tissue Sealant), By Material (Chitosan-based Products, Mineral based Products), By Application (Trauma, General Surgery, Minimally Invasive Surgery, Gynecology Others), By End-User (Hospitals, Ambulatory Surgical Centers, Research Institutes), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Overview

In 2023, the market for hemostasis and tissue sealing agents was estimated to be worth USD 8.39 billion. The Hemostasis and Tissue Sealing Agents Market is expected to increase from USD 9.02 billion in 2024 to USD 18.19 billion by 2032, with a compound annual growth rate (CAGR) of 8.04% over the forecast period (2024-2032). Rising rates of traffic accidents and chronic blood problems, a global demand for minimally invasive procedures, and an aging population are driving market expansion.

The increasing prevalence of chronic blood diseases is another element driving market growth. Individuals with certain blood disorders, such as hemophilia or von Willebrand disease, are more likely to bleed because their clotting factors are compromised. Hemostasis drugs, which enhance blood clotting and limit bleeding, may be required in surgical procedures or medicinal interventions for people with these conditions. For example, the International Society on Thrombosis and Hemostasis' 2022 update estimates that approximately 10 million cases of venous thromboembolism occur globally each year. According to the same source, 544,000 persons in Europe die each year from Deep Vein Thrombosis (DVT).

Market Segment insights

Hemostasis and Tissue Sealing Agents Product-based market segmentation includes Topical Hemostat and adhesive & tissue sealant.

The market is segmented by material, which comprises chitosan-based products and mineral-based products.

The market is segmented by end user, which includes hospitals, ambulatory surgical centers, and research institutes.

Regional insights

The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. The North American Hemostasis and Tissue Sealing Agents market had the biggest market share in 2023. Because of the aging population, the rising prevalence of chronic diseases, and the ongoing advancement of medical technology. With a focus on improving patient outcomes and lowering postoperative complications, the market has evolved into a hub for research and development, resulting in the introduction of novel treatments with superior efficacy.

The European Hemostasis and Tissue Sealing Agents market is estimated to account for the second-largest market share due to favorable health policies and a tendency toward combining Hemostasis and Tissue Sealing Agents, including counseling. Furthermore, the German Hemostasis and Tissue Sealing Agents market was found to have the greatest market share, while the French Hemostasis and Tissue Sealing Agents market is predicted to be the fastest-growing market in the European area.

The Asia-Pacific Hemostasis and Tissue Sealing Agents market is estimated to develop at the quickest rate between 2024 and 2032. This is the result of rapid economic expansion, a growing middle class, and greater urbanization. The region's growing population fuels demand for healthcare, technology, and consumer products. Robust investments in infrastructure, education, and technology drive industrial development and innovation.

The Middle East, Africa, and Latin America are all part of the Rest of the World. The primary drivers driving the rise of Hemostasis and Tissue Sealing Agents in the Middle East and Africa. MEA region has experienced. Increased healthcare spending and infrastructure expansion are boosting demand for innovative medical equipment.

Key Market Players

Johnson & Johnson (US), B Braun Medical Inc (Germany), Teleflex Incorporated (US), Medtronic (Ireland), Baxter (US), Medtrade Products Limited (UK), Axio Biosolutions Pvt Ltd (India), MIL Laboratories Pvt. Ltd (India), Becton, Dickinson, and Company (US), and Pfizer Inc (US) are the market's leading players.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 Data Mining Process
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 Secondary Research data flow:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 Primary Research Data Flow:
    • 3.5.2 Primary Research: Number of Interviews conducted
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 Revenue Analysis Approach
  • 3.7 DATA FORECASTING
    • 3.7.1 Data forecasting Technique
  • 3.8 DATA MODELLING
    • 3.8.1 Microeconomic Factor Analysis:
    • 3.8.2 Data Modelling:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.1 DRIVERS
    • 4.1.1 Growing Incidences Of Road Accidents And Chronic Blood Disorders
    • 4.1.2 Growing Preference Of Minimally Invasive Procedures
  • 4.2 RESTRAINTS
    • 4.2.1 High Costs and Stringent Regulatory Requirements
  • 4.3 OPPORTUNITY
    • 4.3.1 Growing Incidences Of Road Accidents And Growing Geriatric Population

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 Research & Development
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution
    • 5.1.4 Marketing & Sales
    • 5.1.5 Post-Sales Monitoring
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 bargaining power of buyers
    • 5.2.2 Bargaining Power of Suppliers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 Intensity of Rivalry
  • 5.3 IMPACT OF COVID-19
  • 5.4 HEMOSTASIS AND TISSUE SEALING AGENTS FOR MILITARY PURPOSE

6 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 TOPICAL HEMOSTAT
    • 6.2.1 Active
    • 6.2.2 Mechanical
    • 6.2.3 Flowable
  • 6.3 ADHESIVE & TISSUE SEALANT
    • 6.3.1 Synthetic Tissue Sealant
    • 6.3.2 Natural Tissue Sealant
    • 6.3.3 Adhesion Barrier Products

7 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL

  • 7.1 OVERVIEW
  • 7.2 CHITOSAN-BASED PRODUCTS
  • 7.3 MINERAL BASED PRODUCTS

8 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION

  • 8.1 OVERVIEW
  • 8.2 TRAUMA
    • 8.2.1 Burns
    • 8.2.2 Accidents
      • 8.2.2.1 Major Accidents
      • 8.2.2.2 Minor Accidents
    • 8.2.3 Others
  • 8.3 GENERAL SURGERY
  • 8.4 MINIMALLY INVASIVE SURGERY
  • 8.5 GYNAECOLOGY
  • 8.6 OTHERS

9 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 HOSPITALS
    • 9.2.1 Public
    • 9.2.2 Private
    • 9.2.3 Military
  • 9.3 AMBULATORY SURGICAL CENTERS
    • 9.3.1 Independent Ambulatory Surgical Centers
    • 9.3.2 Military Ambulatory Surgical Centers
  • 9.4 RESEARCH INSTITUTES

10 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 Germany
    • 10.3.2 France
    • 10.3.3 UK
    • 10.3.4 Italy
    • 10.3.5 spain
    • 10.3.6 Rest of Europe
  • 10.4 ASIA-PACIFIC
    • 10.4.1 China
    • 10.4.2 India
    • 10.4.3 Japan
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 REST OF THE WORLD
    • 10.5.1 Middle East & Africa
    • 10.5.2 South America

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET SHARE ANALYSIS,
  • 11.3 COMPETITOR DASHBOARD
  • 11.4 PUBLIC PLAYERS STOCK SUMMARY
  • 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 product launch / Product approval
    • 11.6.2 Acquisition

12 COMPANY PROFILES

  • 12.1 JOHNSON & JOHNSON SERVICES, INC
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 productS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 B. BRAUN SE
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 products OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 KEY STRATEGIES
  • 12.3 MIL LABORATORIES PVT. LTD
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 productS OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 KEY STRATEGIES
  • 12.4 BECTON, DICKINSON, AND COMPANY
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 KEY STRATEGIES
  • 12.5 PFIZER INC.
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 SWOT ANALYSIS
    • 12.5.6 KEY STRATEGIES
  • 12.6 TELEFLEX INCORPORATED
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 TELEFLEX INCORPORATED: kEY DEVELOPMENTS
    • 12.6.6 KEY STRATEGIES
  • 12.7 MEDTRONIC
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 SWOT ANALYSIS
    • 12.7.6 KEY STRATEGIES
  • 12.8 BAXTER
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 SWOT ANALYSIS
    • 12.8.6 KEY STRATEGIES
  • 12.9 MEDTRADE PRODUCTS LIMITED
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 SWOT ANALYSIS
    • 12.9.6 KEY STRATEGIES
  • 12.10 AXIO BIOSOLUTIONS PVT LTD
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 KEY STRATEGIES

13 DATA CITATIONS